Clinical trial
Preference of Life-Sustaining Treatment Among Patients With End Stage Renal Disease
NCT05878171 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preference of Life-Sustaining Treatment Among Patients With End Stage Renal Disease
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 22, 2023
- Completion date
- April 30, 2025
- Enrollment
- 200 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease